REED - Revista Española de Enfermedades Digestivas

Alerta del nuevo número	Contacto
Envío de artículos	Síguenos REEDigestivas_
English version

Año 2015 / Volumen 107 / Número 10
Original

Impact of the age of diagnosis on the natural history of ulcerative colitis

614-621

DOI: 10.17235/reed.2015.3736/2015

Tiago Cúrdia Gonçalves, Francisca Dias de Castro, Joao Firmino Machado, Maria Joao Moreira, Bruno Rosa, José Cotter,

Resumen

Background: Ulcerative colitis (UC) has a recognized phenotypic heterogeneity. Some studies suggest that age at diagnosis may influence features and natural history of the disease. Aim: This study aimed to compare patients’, disease’s and treatment’s features between Portuguese patients diagnosed before and after the age of 40-years-old. Methods: Retrospective single-center study that included 310 patients with UC, divided in two groups: Those diagnosed before the age of 40-years-old (early onset UC) and those diagnosed later than that (late onset UC). In each group features of the patients (gender, family history, smoking), of the disease (duration, extension, severity, clinical course, hospitalization, extraintestinal manifestations), and of treatment (oral aminosalicylates, systemic steroids or immunomodulators) were analyzed. Statistical analysis was performed using SPSSv22.0. Univariate and multivariate analyses were performed to assess factors associated with early and late onset UC. Results: From the analyzed patients, 207 had UC diagnosed before the age of 40 years old (43.5% men; mean age at diagnosis 29.4 ± 6.9 years) and 103 were diagnosed after that age (61.2% men; mean age at diagnosis 51.8 ± 8.1 years). In the group diagnosed before 40 years old, female gender (p = 0.003), severe disease (p = 0.002), chronic intermittent clinical course (p = 0.026), and hospitalizations (p = 0.001) were significantly more frequent. The use of oral aminosalicylates (p = 0.032), systemic steroids (p = 0.003) and immunomodulators (p = 0.012) were also more common in the early onset UC group. No differences between groups were found in family history, smoking, disease’s extension, extraintestinal manifestations, and use of biological agents. Multivariate analysis pointed early onset UC to be significantly associated with female gender (odds ratio [OR], 1.77; 95% confidence interval [CI], 1.08-2.91; p = 0.024), chronic intermittent symptoms (OR, 2.34; 95% CI, 1.17-4.70; p = 0.016), and need of hospitalization (OR, 2.89; 95% CI, 1.46-5.72; p = 0.002). Conclusions: When diagnosed before the age of 40-yearsold, UC preferably affects women and manifests as a more severe disease, with more frequent hospitalizations and chronic intermittent symptoms. These facts might have implications in planning timely and individualized future therapeutic strategies.

Nuevo comentario

Comentarios

01/03/2023 3:48:56
Golden State Urology Stockton
3133 Ԝ Marϲh Ln Suite 1040B,
Stockton, ᏟA 95219, United Stаtеs
+12094643627
hоw much does іt cost to get a vaeectomy reversed

Bibliografía

1. Podolsky DK. Inflammatory bowel disease. The New England journal of medicine. 2002;347(6):417-29.

DOI: 10.1056/NEJMra020831

2. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut. 1996;39(5):690-7.

DOI: 10.1136/gut.39.5.690

3. Tragnone A, Corrao G, Miglio F, Caprilli R, Lanfranchi GA. Incidence of inflammatory bowel disease in Italy: a nationwide population-based study. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). International journal of epidemiology. 1996;25(5):1044-52.

DOI: 10.1093/ije/25.5.1044

4. Azevedo LF, Magro F, Portela F, Lago P, Deus J, Cotter J, et al. Estimating the prevalence of inflammatory bowel disease in Portugal using a pharmaco-epidemiological approach. Pharmacoepidemiology and drug safety. 2010;19(5):499-510.

DOI: 10.1002/pds.1930

5. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140(6):1785-94.

DOI: 10.1053/j.gastro.2011.01.055

6. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46-54 e42; quiz e30.

DOI: 10.1053/j.gastro.2011.10.001

7. Ha CY, Newberry RD, Stone CD, Ciorba MA. Patients with late-adult-onset ulcerative colitis have better outcomes than those with early onset disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2010;8(8):682-7 e1.

DOI: 10.1016/j.cgh.2010.03.022

8. Loftus EV, Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004;126(6):1504-17.

DOI: 10.1053/j.gastro.2004.01.063

9. Carr N, Schofield PF. Inflammatory bowel disease in the older patient. The British journal of surgery. 1982;69(4):223-5.

DOI: 10.1002/bjs.1800690418

10. Zimmerman J, Gavish D, Rachmilewitz D. Early and late onset ulcerative colitis: distinct clinical features. Journal of clinical gastroenterology. 1985;7(6):492-8.

DOI: 10.1097/00004836-198512000-00010

11. Riegler G, Tartaglione MT, Carratu R, D'Inca R, Valpiani D, Russo MI, et al. Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis: a study by GISC (Italian Colon-Rectum Study Group). Digestive diseases and sciences. 2000;45(3):462-5.

DOI: 10.1023/A:1005424603085

12. Hadithi M, Cazemier M, Meijer GA, Bloemena E, Felt-Bersma RJ, Mulder CJ, et al. Retrospective analysis of old-age colitis in the Dutch inflammatory bowel disease population. World journal of gastroenterology : WJG. 2008;14(20):3183-7.

DOI: 10.3748/wjg.14.3183

13. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Canadian journal of gastroenterology = Journal canadien de gastroenterologie. 2005;19 Suppl A:5A-36A.

14. Loftus EV, Jr., Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Alimentary pharmacology & therapeutics. 2002;16(1):51-60.

DOI: 10.1046/j.1365-2036.2002.01140.x

15. Portela F, Magro F, Lago P, Cotter J, Cremers I, de Deus J, et al. Ulcerative colitis in a Southern European country: a national perspective. Inflammatory bowel diseases. 2010;16(5):822-9.

DOI: 10.1002/ibd.21119

16. Barreiro-de Acosta M, Magro F, Carpio D, Lago P, Echarri A, Cotter J, et al. Ulcerative colitis in northern Portugal and Galicia in Spain. Inflammatory bowel diseases. 2010;16(7):1227-38.

DOI: 10.1002/ibd.21170

17. Solberg IC, Lygren I, Jahnsen J, Aadland E, Hoie O, Cvancarova M, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scandinavian journal of gastroenterology. 2009;44(4):431-40.

DOI: 10.1080/00365520802600961

18. Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. Journal of Crohn's & colitis. 2012;6(10):965-90.

DOI: 10.1016/j.crohns.2012.09.003

19. Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. The American journal of gastroenterology. 2006;101(6):1274-82.

DOI: 10.1111/j.1572-0241.2006.00552.x

20. Loftus CG, Loftus EV, Jr., Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ, 3rd, et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflammatory bowel diseases. 2007;13(3):254-61.

DOI: 10.1002/ibd.20029

21. Ott C, Obermeier F, Thieler S, Kemptner D, Bauer A, Scholmerich J, et al. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study. European journal of gastroenterology & hepatology. 2008;20(9):917-23.

DOI: 10.1097/MEG.0b013e3282f97b33

22. Matsumoto S, Miyatani H, Yoshida Y. Ulcerative colitis: comparison between elderly and young adult patients and between elderly patients with late-onset and long-standing disease. Digestive diseases and sciences. 2013;58(5):1306-12.

DOI: 10.1007/s10620-012-2517-5

23. Charpentier C, Salleron J, Savoye G, Fumery M, Merle V, Laberenne JE, et al. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut. 2014;63(3):423-32.

DOI: 10.1136/gutjnl-2012-303864

24. Gower-Rousseau C, Dauchet L, Vernier-Massouille G, Tilloy E, Brazier F, Merle V, et al. The natural history of pediatric ulcerative colitis: a population-based cohort study. The American journal of gastroenterology. 2009;104(8):2080-8.

DOI: 10.1038/ajg.2009.177

25. Regueiro M, Kip KE, Cheung O, Hegazi RA, Plevy S. Cigarette smoking and age at diagnosis of inflammatory bowel disease. Inflammatory bowel diseases. 2005;11(1):42-7.

DOI: 10.1097/00054725-200501000-00006

26. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749-53.

DOI: 10.1136/gut.2005.082909

27. Kalkan IH, Dagli U, Oztas E, Tunc B, Ulker A. Comparison of demographic and clinical characteristics of patients with early vs. adult vs. late onset ulcerative colitis. European journal of internal medicine. 2013;24(3):273-7.

DOI: 10.1016/j.ejim.2012.12.014

28. Sarlos P, Kovesdi E, Magyari L, Banfai Z, Szabo A, Javorhazy A, et al. Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature. World journal of gastrointestinal pathophysiology. 2014;5(3):304-21.

29. Ruel J, Ruane D, Mehandru S, Gower-Rousseau C, Colombel JF. IBD across the age spectrum: is it the same disease? Nature reviews Gastroenterology & hepatology. 2014;11(2):88-98.

DOI: 10.1038/nrgastro.2013.240

30. Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clinic proceedings. 2006;81(11):1462-71.

DOI: 10.4065/81.11.1462

31. Hoie O, Wolters F, Riis L, Aamodt G, Solberg C, Bernklev T, et al. Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. The American journal of gastroenterology. 2007;102(8):1692-701.

DOI: 10.1111/j.1572-0241.2007.01265.x

32. Bringiotti R, Ierardi E, Lovero R, Losurdo G, Di Leo A, Principi M. Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? World journal of gastrointestinal pathophysiology. 2014;5(4):550-9.

DOI: 10.4291/wjgp.v5.i4.550

33. Chen WX, Ren LH, Shi RH. Enteric microbiota leads to new therapeutic strategies for ulcerative colitis. World journal of gastroenterology : WJG. 2014;20(42):15657-63.

DOI: 10.3748/wjg.v20.i42.15657

34. Quezada SM, Cross RK. Association of age at diagnosis and ulcerative colitis phenotype. Digestive diseases and sciences. 2012;57(9):2402-7.

DOI: 10.1007/s10620-012-2081-z

35. Turner D, Levine A, Escher JC, Griffiths AM, Russell RK, Dignass A, et al. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. Journal of pediatric gastroenterology and nutrition. 2012;55(3):340-61.

DOI: 10.1097/MPG.0b013e3182662233

36. Dignass A, Lindsay JO, Sturm A, Windsor A, Colombel JF, Allez M, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. Journal of Crohn's & colitis. 2012;6(10):991-1030.

DOI: 10.1016/j.crohns.2012.09.002

37. Lakatos PL, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, et al. IBD in the elderly population: results from a population-based study in Western Hungary, 1977-2008. Journal of Crohn's & colitis. 2011;5(1):5-13.

DOI: 10.1016/j.crohns.2010.08.004

Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica

Este artículo ha sido visitado 868 veces.
Este artículo ha sido descargado 21 veces.

Estadísticas de Dimensions

Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 17/02/2015

Aceptado: 26/05/2015

Prepublicado: 22/06/2015

Publicado: 25/09/2015

Tiempo de revisión del artículo: 91 días

Tiempo de prepublicación: 125 días

Tiempo de edición del artículo: 220 días

Este artículo ha sido valorado por 1 lectores .

Valoración del lector:

Valora este artículo:

Envío y seguimiento de artículos

Normas de publicación

Artículos

Guías de práctica clínica

Revisiones

Artículos destacados

Envío de artículos

Información para los autores

Servicio de traducción

Tiempo editorial – Tiempo de publicación

Revista

Información para revisores

Información para anunciantes

Artículos

Guías de práctica clínica

Revisiones

Artículos destacados

Envío de artículos

Información para los autores

Servicio de traducción

Tiempo editorial – Tiempo de publicación

Revista

Información para revisores

Información para anunciantes

Artículos

Guías de práctica clínica

Revisiones

Artículos destacados

Envío de artículos

Información para los autores

Servicio de traducción

Tiempo editorial – Tiempo de publicación

Revista

Información para revisores

Información para anunciantes

Centenario REED

Open access

Artículos en prensa

Cookie	Finalidad	Caducidad	Tipo de cookie
ASP.NET_SessionId	Hacen posible el control de tráfico desde el servidor a múltiples usuarios a la vez, la identificación y el acceso como usuario.	Cierre de sesión / Fin de proyecto	Sesión
cookiesDirective	Hacen posible recordar la configuración de las cookies.	Cierre de sesión / Fin de proyecto	Sesión
vercookies	Hacen posible mostrar el aviso del uso de cookies.	Cierre de sesión / Fin de proyecto	Sesión

Descargar en un gestor de citas

Estadísticas de Dimensions

Estadísticas de Plum Analytics

Envío y seguimiento de artículos

¿Quieres recibir cada mes el boletín digital de la REED?

De acuerdo con la legislación vigente, esta publicación está destinada exclusivamente a profesionales del sector sanitario.